Release Date: 25/08/10 13:27 Summary: Results Announcement, Appendix 4E, and Annual Report Price Sensitive: Yes Download Document 760.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%